Department of Biotechnology

DBT: Delivering a Better Tomorrow We are into an era where #biotechnology is going to lead the next Industrial Revolution. With policies, schemes, initiatives, research, innovations and startup ecosystem, the DBT is laying the foundation for a better tomorrow. Catch a glimpse of #11YearsofScientificInnovations @DrJitendraSingh @rajesh_gokhale

Tiny bacteria. Big implications for agriculture. What if a common weed held the key to understanding how plant pathogens evolve? @DBTIndia-supported researchers have decoded the complete genomes of two phytoplasma strains infecting Parthenium hysterophorus, uncovering an unexpected genetic strategy that helps these crop-threatening bacteria adapt and survive—even after losing key evolutionary elements. This breakthrough expands our understanding of plant-pathogen evolution and strengthens the scientific foundation for protecting crops and advancing sustainable agriculture. Explore the latest edition of #ScienceInSlides and discover how genomics is transforming agricultural research. #Genomics #PlantScience #Phytoplasma @DrJitendraSingh @rajesh_gokhale @BricDbt @DBT_NCCS_Pune @NABI_India @bric_ils @HydNiab @NIPGRsocial @NImmunology @BRIC_CDFD @ICGEBNewDelhi @DBT_NBRC @RGCB_Trivandrum @DBT_IBSD @THSTIFaridabad @unescorcb @FollowDbtNibmg @NImmunology @BIRAC_2012

Time for another #DBTQuest! How well do you know India's biotechnology ecosystem? Can you identify the digital platform that serves as @DBTIndia's central repository for biosafety compliance and regulatory submissions? Drop your answer (A, B, C or D) in the comments and put your biotech knowledge to the test. Stay tuned for the answer! #KnowDBT #Biosafety #Biotechnology #DBTQuiz @DrJitendraSingh @rajesh_gokhale @BricDbt @DBT_NCCS_Pune @NABI_India @bric_ils @HydNiab @NIPGRsocial @NImmunology @BRIC_CDFD @ICGEBNewDelhi @DBT_NBRC @RGCB_Trivandrum @DBT_IBSD @THSTIFaridabad @unescorcb @FollowDbtNibmg @IISERPune @iiserkol @IiserMohali @IiserTirupati @iiserbhopal @tvmiiser @IISER_BERHAMPUR @iitdelhi @iitbombay @iitmadras @IITKanpur @IITKgp

12 Years. Countless Breakthroughs. One Journey of Impact. BIOECONOMY & NATIONAL GROWTH: 12 YEARS OF TRANSFORMATION From a $10 billion bioeconomy in 2014 to $195.3 billion in 2025, India's biotechnology sector has undergone a remarkable transformation. This booklet chronicles the policies, infrastructure, and strategic initiatives that have positioned India as a global biotech leader — from the BioE3 Policy and Biofoundry Networks to space biotechnology collaborations. A roadmap toward a $300 billion bioeconomy by 2030, powered by innovation at scale. Read the booklet: dbt.gov.in/resources/dbt-… Celebrating 12 Years of DBT's Impact on Science, Innovation, Society and Nation Building. #Bioeconomy #ViksitBharat2047 #ScienceForSociety #AtmanirbharBharat @DrJitendraSingh @rajesh_gokhale @bricdbt @FollowDbtNibmg @NABI_India @bric_ils @HydNiab @NIPGRsocial @NImmunology @BRIC_CDFD @DBT_NCCS_Pune @ICGEBNewDelhi @DBT_NBRC @RGCB_Trivandrum @DBT_IBSD @THSTIFaridabad @unescorcb @CSIR_IND @BIRAC_2012 @DSTIndia

⏰ Last Day to Apply! Today is the final opportunity to submit your idea for the 9th Window of Category 2 of the D.E.S.I.G.N. for BioE3 Challenge! 🚀 Students, Researchers, Innovators & Startups Have an innovative solution that can contribute to a sustainable and bio-enabled future? Don't miss this chance to turn your idea into impact. 📅 Application Deadline: Today, 20 July 2026 (11:59PM) 👉 Submit your entry now: bric.nic.in/bioe3challenge/ #DESIGNforBioE3 #BioE3Challenge #StartupIndia #ViksitBharat @DrJitendraSingh @rajesh_gokhale @BricDbt @DBT_NCCS_Pune @NABI_India @bric_ils @HydNiab @NIPGRsocial @NImmunology @BRIC_CDFD @ICGEBNewDelhi @DBT_NBRC @RGCB_Trivandrum @DBT_IBSD @THSTIFaridabad @unescorcb @FollowDbtNibmg @IISERPune @iiserkol @IiserMohali @IiserTirupati @iiserbhopal @tvmiiser @IISER_BERHAMPUR @iitdelhi @iitbombay @iitmadras @IITKanpur @IITKgp

🚨 Last Day to Apply! Today is your final chance to participate in the 9th Window of Category 1 of the D.E.S.I.G.N. for BioE3 Challenge! 🎓 School Students (Classes VI–XII) Do you have an innovative idea that can help build a sustainable and bio-enabled future? Submit your idea today and take the first step towards making a real impact. 📅 Application Deadline: Today, 20 July 2026 (5:30 PM) 👉 Submit your entry now: 🔗 innovateindia.mygov.in/bioe3/ #DESIGNforBioE3 #BioE3Challenge #ViksitBharat #StartupIndia @DrJitendraSingh @rajesh_gokhale @BricDbt @DBT_NCCS_Pune @NABI_India @bric_ils @HydNiab @NIPGRsocial @NImmunology @BRIC_CDFD @ICGEBNewDelhi @DBT_NBRC @RGCB_Trivandrum @DBT_IBSD @THSTIFaridabad @unescorcb @FollowDbtNibmg @KVS_HQ @cbseindia29

India’s Yuva Shakti continues to make a mark globally! Congratulations to our team of Debadatta Priyadarshi, Harshit Singhal, Kabeer Chhillar and Sandeep Kuchi for winning Gold Medals at the 58th International Chemistry Olympiad. This was India’s best performance at this prestigious platform. Their brilliance, dedication and passion for science have made the entire nation proud. It will also motivate countless young minds to study and excel in chemistry.

It is a matter of immense happiness that in the 37th International Biology Olympiad held in Vilnius, Lithuania, all four Indian team members secured medals, including one Gold. Proud of Bhavyaa Gunwal, Soumil Maity, Nishit Kalani and Anmol Kumar for their success at the Olympiad. They have shown immense knowledge of subjects like Molecular Biology and Biochemistry, Animal Physiology, Animal Morphology and Systematics as well as Plant Computational Biology. I am certain that this success will encourage several more youngsters.

Addressed the gathering after releasing the Book “UNBROKEN: My Battle with Cancer”, authored by Cancer survivor and eminent Scientist Dr Akhilesh Gupta. Key Takeaways: "The book 'UNBROKEN: My Battle with Cancer' is much more than a personal memoir, it chronicles an extraordinary journey of courage, resilience, integrity and unwavering faith in medical science. Non-communicable diseases have emerged as one of the country's biggest public health challenges. Cancer, Diabetes, obesity, fatty liver disease and other metabolic disorders are rising across all regions and are increasingly affecting younger populations. However, several cancers are now curable or manageable if diagnosed early, followed by prompt medical intervention. India's response to the growing burden of Cancer, Diabetes, obesity and other non-communicable diseases must move beyond hospitals and become a mass public movement. The country today not only requires greater dissemination of evidence-based health information but also a check on the alarming spread of misinformation, particularly relating to nutrition, diet and obesity".

#HealthMusings #Doordarshan

My Address after the successful Launch of India’s first Private Orbital Rocket “Vikram-1 Skyroot” from #Sriharikota. #IndiaWithVikram1

Proud of you! It is a matter of immense happiness that at the 37th #International #Biology_Olympiad held in Vilnius, Lithuania, all four members of the Indian team secured medals, including one Gold. Proud of Bhavyaa Gunwal, Soumil Maity, Nishit Kalani and Anmol Kumar for their outstanding achievement. Their success reflects the growing scientific talent of India's youth in fields such as Molecular Biology, Biochemistry and Computational Biology. The achievement also underscores the expanding opportunities in #Biotechnology under Prime Minister Narendra Modi's vision, with initiatives such as the BioE3 Policy fostering innovation, research and biomanufacturing in India. May their accomplishment inspire many more young minds to pursue science and innovation for the nation. #DBT

Just 1 Day Left! Tomorrow, the 9th Month Window for The D.E.S.I.G.N. for the BioE3 Challenge (Category 2) closes! This is your final opportunity to fine-tune your idea, strengthen your proposal, and submit. 📅 Last Date to Apply: 20th July 2026 (11:59 PM) 📍 Submit your entry here: bric.nic.in/bioe3challenge/ #BioE3 #DESIGNChallenge #BioEconomy #StartupIndia @DrJitendraSingh @rajesh_gokhale @BricDbt @DBT_NCCS_Pune @NABI_India @bric_ils @HydNiab @NIPGRsocial @NImmunology @BRIC_CDFD @ICGEBNewDelhi @DBT_NBRC @RGCB_Trivandrum @DBT_IBSD @THSTIFaridabad @unescorcb @FollowDbtNibmg @IISERPune @iiserkol @IiserMohali @IiserTirupati @iiserbhopal @tvmiiser @IISER_BERHAMPUR @iitdelhi @iitbombay @iitmadras @IITKanpur @IITKgp

Only 1 Day Left! The countdown has begun for 9th Window of Category 1 of the D.E.S.I.G.N. for BioE3 Challenge ! School Students (Classes VI–XII) If you have an innovative idea that can shape a sustainable future, this is your chance to showcase it. 📅 Last Date to Apply: 20th July 2026 (5:30 PM) 👉Submit your entry here: 🔗innovateindia.mygov.in/bioe3/ #DESIGNforBioE3 #BioE3Challenge #viksitbharat #StartupIndia @DrJitendraSingh @rajesh_gokhale @BricDbt @DBT_NCCS_Pune @NABI_India @bric_ils @HydNiab @NIPGRsocial @NImmunology @BRIC_CDFD @ICGEBNewDelhi @DBT_NBRC @RGCB_Trivandrum @DBT_IBSD @THSTIFaridabad @unescorcb @FollowDbtNibmg @KVS_HQ @cbseindia29

The answer is out! The correct answer to this edition of #DBTQuest is @BIRAC_2012 (Biotechnology Industry Research Assistance Council) — a @DBTIndia-supported organization that has played a pivotal role in fostering India's biotechnology startup ecosystem by enabling innovation, entrepreneurship, and technology translation. Congratulations to everyone who got it right! Keep participating in DBT Quest and discover the people, institutions, and innovations shaping India's biotechnology journey. Stay tuned for the next challenge! #KnowDBT #Biotechnology #StartupEcosystem @DrJitendraSingh @rajesh_gokhale @BricDbt @DBT_NCCS_Pune @NABI_India @bric_ils @HydNiab @NIPGRsocial @NImmunology @BRIC_CDFD @ICGEBNewDelhi @DBT_NBRC @RGCB_Trivandrum @DBT_IBSD @THSTIFaridabad @unescorcb @FollowDbtNibmg

#ScienceInSlides Can two familiar medicines become a new weapon against one of the deadliest brain cancers? @DBTIndia-supported researchers have developed a patented therapeutic strategy that combines two established drugs to target high-grade glioma, an aggressive form of brain cancer with limited treatment options. By activating the tumour-suppressor protein Par-4, this novel combination promotes cancer cell death and demonstrated greater effectiveness in laboratory studies than either drug alone. With both medicines already clinically established for other conditions, this approach highlights the promise of drug repurposing in accelerating the path toward future cancer therapies. Swipe through to discover how this innovative strategy works, and scan the QR code to explore the complete patent. #CancerResearch #Glioma #DrugRepurposing @DrJitendraSingh @rajesh_gokhale @BricDbt @DBT_NCCS_Pune @NABI_India @bric_ils @HydNiab @NIPGRsocial @NImmunology @BRIC_CDFD @ICGEBNewDelhi @DBT_NBRC @RGCB_Trivandrum @DBT_IBSD @THSTIFaridabad @unescorcb @FollowDbtNibmg @BIRAC